Mechanisms of Deep Vein Thrombosis (DVT) and Vein Wall Fibrosis

Summary

The goal of this study is to determine the safety and tolerability or efficacy of adjunctive treatments (including rosuvastatin 20 mg daily) in combination with standard anticoagulation therapy (Factor Xa inhibitors) in patients with lower extremity deep vein thrombosis (DVT). The efficacy of adjunctive treatments to prevent the development of post thrombotic syndrome (PTS) after DVT will be evaluated.

Timeline

Start

2021-06-01

Primary completion

2025-06-01

Completion

2025-06-01

Drugs

Indications